Pharmacoepidemiology

  • Pharmacoepidemiology
    By Stanley Edlavitch

    Brown RB, Klar J, Lemeshow S, et al: Enhanced bleeding with cefoxitin or moxalactam: Statistical analysis within a defined population of 1493 patients. Arch Intern Med 1986;146:2159–2164. 8. Jick H, Miettinen OS: Regular aspirin use and ...

  • Pharmacoepidemiology: An Introduction
    By Abraham G. Hartzema, Miquel S. Porta, Hugh Hanna Tilson

    Pharmacoepidemiology: An Introduction

  • Pharmacoepidemiology
    By Brian L. Strom, Stephen E. Kimmel, Sean Hennessy

    Integrating multiple perspectives from academia, industry, and regulatory agencies, this comprehensive volume has been fully revised and updated to provide first-class guidance for anyone in need of up-to-date information on all aspects of ...

  • Pharmacoepidemiology
    By Brian L. Strom

    "This is an important and comprehensive contribution to anessential area of scientific and public health enquiry and will beof use both as an introduction to pharmacoepidemiology and as areference source for academics, public health ...

  • Pharmacoepidemiology
    By Brian L. Strom, Stephen E. Kimmel, Sean Hennessy

    One concern noted was that numerical benefit information has the potential to influence patient behavior and could lead to the ... In the United States, all prescription medications are required to have an FDA‐approved package insert, ...

  • Pharmacoepidemiology: Principles and Practice
    By Brenda Waning, Michael Montagne

    The not-to-be-missed, benchmark volume on the growing area of stud in the PharmD pharmacy curriculum.

  • Pharmacoepidemiology
    By Brian L. Strom, Stephen E. Kimmel, Sean Hennessy

    Assessment of therapeutic risk management programs Therapeutic risk management is attracting immense interest in pharmacovigilance (see Chapter 29). The management of risk of medicines requires identification, measurement, ...

  • Pharmacoepidemiology
    By Stanley Edlavitch

    Numerous tables and figures are included to illustrate many of the papers within the text. This book offers substantial reading for epidemiologists and individuals interested in the field of pharmacoepidemiology.

  • Pharmacoepidemiology
    By Brian L. Strom, Stephen E. Kimmel, Sean Hennessy

    This edition has been fully revised and updated throughout and continues to provide a rounded view on all perspectives from academia, industry and regulatory bodies, addressing data sources, applications and methodologies with great clarity ...

  • Pharmacoepidemiology
    By Stanley Edlavitch

    Numerous tables and figures are included to illustrate many of the papers within the text. This book offers substantial reading for epidemiologists and individuals interested in the field of pharmacoepidemiology.

  • Pharmacoepidemiology: Post Marketing Pharmacoepidemiology
    By Ravi Humbarwadi

    Pharmacoepidemiology. NIS (Non- Interventional Study), PASS ( Post Authorisation Safety Studies), Drug Utilization Studies, Drug Use Pattern, Automated Databases, CER ( comparative effectiveness research).